SCHEMBL2541946

SCHEMBL2541946

CC(=O)Oc1ccc(C)nc1Cn1c(N)nc2ccc(CNc3ccccc3C)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 9/20 0.37
▸ LMNA P02545 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ SCD O00767 2/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ TNF P01375 1/20 0.34
▸ CXCL8 P10145 1/20 0.34
▸ SOS1 Q07889 1/20 0.34
▸ NOD2 Q9HC29 1/20 0.34
▸ NOD1 Q9Y239 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL2541944 0.86 ACSS2 (0.37) CSF1RSMN1; SMN2SCDNPC1PKM
SCHEMBL12226825 0.75 CSF1R (0.46) CSF1RSMN1; SMN2CYP1A2CYP3A4CYP2D6
SCHEMBL12226831 0.74 SOS1 (0.35) CSF1RLMNASMN1; SMN2SCDPKM
SCHEMBL12226826 0.73 KMT2A (0.34) CSF1RSCDPKMHTTTNF
SCHEMBL8284704 0.72 LMNA (0.40) CSF1RLMNASMN1; SMN2CYP1A2CYP3A4
SCHEMBL8286263 0.72 CSF1R (0.44) CSF1RLMNASMN1; SMN2CYP1A2CYP3A4
SCHEMBL8284703 0.72 CSF1R (0.47) CSF1RHTTSOS1
SCHEMBL2537168 0.70 MAPT (0.46) SMN1; SMN2SCDNPC1PKMRAB9A
SCHEMBL8286213 0.70 CSF1R (0.53) CSF1RHTT
SCHEMBL8247680 0.68 TLR8 (0.42) CSF1RHTTSOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044073-B2 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2011-10-25 — — US disclosed
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-2, H1-4 CSF1R 4129/4885LMNA 1566/4885SMN1; SMN2 1665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback